BerGenBio ASA (OSL: BGBIO)
Norway
· Delayed Price · Currency is NOK 10.90
-0.18 (-1.62%)
Aug 30, 2024, 4:25 PM CET
BerGenBio ASA Revenue
BerGenBio ASA had revenue of 521.00K NOK in the twelve months ending June 30, 2024, up 33.93% year-over-year. In the year 2023, BerGenBio ASA had annual revenue of 354.00K, down -9.00%.
Revenue (ttm)
521.00K
Revenue Growth
+33.93%
P/S Ratio
605.66
Revenue / Employee
34.73K
Employees
16
Market Cap
426.05M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 354.00K | -35.00K | -9.00% |
| Dec 31, 2022 | 389.00K | -385.00K | -49.74% |
| Dec 31, 2021 | 774.00K | 173.00K | 28.79% |
| Dec 31, 2020 | 601.00K | -8.30M | -93.25% |
| Dec 31, 2019 | 8.90M | 6.57M | 281.16% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 533.17M |
| Nordhealth AS | 471.77M |
| Nykode Therapeutics AS | 69.44M |
| Photocure ASA | 513.58M |
| Carasent ASA | 254.01M |
| ArcticZymes Technologies ASA | 117.80M |
| Hofseth BioCare ASA | 230.08M |
| Gentian Diagnostics ASA | 151.51M |